OncoTherapy Science Statistics

Total Valuation

TYO:4564 has a market cap or net worth of JPY 7.44 billion. The enterprise value is 6.61 billion.

Market Cap	7.44B
Enterprise Value	6.61B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TYO:4564 has 275.64 million shares outstanding. The number of shares has increased by 22.73% in one year.

Current Share Class	275.64M
Shares Outstanding	275.64M
Shares Change (YoY)	+22.73%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	10.67%
Owned by Institutions (%)	-0.96%
Float	246.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.92
PB Ratio	10.22
P/TBV Ratio	10.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-8.11
EV / Sales	8.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.38

Current Ratio	3.38
Quick Ratio	2.85
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-797.00

Financial Efficiency

Return on equity (ROE) is -150.79% and return on invested capital (ROIC) is -92.16%.

Return on Equity (ROE)	-150.79%
Return on Assets (ROA)	-49.27%
Return on Invested Capital (ROIC)	-92.16%
Return on Capital Employed (ROCE)	-96.26%
Revenue Per Employee	15.96M
Profits Per Employee	-17.34M
Employee Count	47
Asset Turnover	0.74
Inventory Turnover	16.60

Taxes

In the past 12 months, TYO:4564 has paid 2.00 million in taxes.

Income Tax	2.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.95% in the last 52 weeks. The beta is 0.01, so TYO:4564's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	-28.95%
50-Day Moving Average	23.52
200-Day Moving Average	28.08
Relative Strength Index (RSI)	57.34
Average Volume (20 Days)	9,220,680

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TYO:4564 had revenue of JPY 750.00 million and -815.00 million in losses. Loss per share was -3.12.

Revenue	750.00M
Gross Profit	-503.00M
Operating Income	-797.00M
Pretax Income	-813.00M
Net Income	-815.00M
EBITDA	n/a
EBIT	-797.00M
Loss Per Share	-3.12

Full Income Statement

Balance Sheet

The company has 833.00 million in cash and n/a in debt, giving a net cash position of 833.00 million or 3.02 per share.

Cash & Cash Equivalents	833.00M
Total Debt	n/a
Net Cash	833.00M
Net Cash Per Share	3.02
Equity (Book Value)	728.00M
Book Value Per Share	2.68
Working Capital	778.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-815.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -67.07%, with operating and profit margins of -106.27% and -108.67%.

Gross Margin	-67.07%
Operating Margin	-106.27%
Pretax Margin	-108.40%
Profit Margin	-108.67%
EBITDA Margin	n/a
EBIT Margin	-106.27%
FCF Margin	n/a

Dividends & Yields

TYO:4564 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.73%
Shareholder Yield	n/a
Earnings Yield	-10.95%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 26, 2013. It was a forward split with a ratio of 500.

Last Split Date	Sep 26, 2013
Split Type	Forward
Split Ratio	500

Scores

TYO:4564 has an Altman Z-Score of -22.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.1
Piotroski F-Score	3